A rare malignancy in an uncommon location: case of a 25-year-old female patient with infiltrative vulvar basal cell carcinoma

Hillary Mercado-Figueroa; Jose Silva-Martinez; Itzamar Pastrana-Echevarria; Alexandra Ortiz-Orama

doi:10.18203/issn.2455-4529.IntJResDermatol20254123

Authors

Hillary Mercado-Figueroa Department of Obstetrics and Gynecology, Hospital Episcopal San Lucas, Ponce, Puerto Rico
Jose Silva-Martinez Department of Obstetrics and Gynecology, Hospital Episcopal San Lucas, Ponce, Puerto Rico
Itzamar Pastrana-Echevarria Department of Graduate Medical Education, Hospital Episcopal San Lucas, Ponce, Puerto Rico
Alexandra Ortiz-Orama Department of Graduate Medical Education, Hospital Episcopal San Lucas, Ponce, Puerto Rico

DOI:

https://doi.org/10.18203/issn.2455-4529.IntJResDermatol20254123

Keywords:

Basal cell carcinoma, Vulvar cancer, Genital skin tumors, Squamous metaplasia

Abstract

Basal cell carcinoma (BCC) of the vulva accounts for less than 1% of all BCCs. Herein this report describes a case of a 25-year-old female with vulvar BCC that was presented as an ulcerated mass lesion with erythema, fissuring and bleeding in the upper region of the right labium majus. After biopsy, the histopathology results showed basal cell carcinoma, mixed nodular and infiltrative type with focal areas of squamous metaplasia confirmed by IHC staining for common BCC markers. The reasoning for this clinical case is to report the atypical presentation and unique histopathology, for future consideration as a differential diagnosis when encountering genital lesions and to contribute to an ideal treatment. Vulvar BCCs remain a rare tumor of the vulva, which has excellent prognosis if managed appropriately. Therefore, any persistent lesion in the vulvar region should be biopsied and examined histologically regardless of the age of the patient.

Metrics

Metrics Loading ...

References

McDaniel B, Steele RB. Basal Cell Carcinoma. In: StatPearls. Treasure Island (FL): StatPearls Publishing. 2025. Available at: https://www.ncbi .nlm.nih.gov/boohttps://www.ncbi.nlm.nih.gov/books/NBK482439/ks/NBK482439/. Accessed on 28 September 2025.

American Cancer Society. Key statistics for basal and squamous cell skin cancers. Atlanta (GA): American Cancer Society. 2023. Available at: https://www.cancer.org/cancer/types/basal-and-squamous-cell-skin-cancer/about/key-statistics.html. Accessed on 28 September 2025.

Renati S, Henderson C, Aluko A, Burgin S. Basal cell carcinoma of the vulva: a case report and systematic review of the literature. Int J Dermatol. 2019;58(8):892-902. DOI: https://doi.org/10.1111/ijd.14307

Asuman C, Ozlem A, Burçak T, Onder P. An unusual location of basal cell carcinoma: the clitoris and the vulva. Indian J Dermatol. 2008;53(4):192-4. DOI: https://doi.org/10.4103/0019-5154.44795

Pineda Reyes JP, Ma L. Basal cell carcinoma – vulva. PathologyOutlines.com. 2024. Available at: https:// www.pathologyoutlines.com/topic/vulvabasalcellcarc.html. Accessed on 28 September 2025.

Marzuka AG, Book SE. Basal cell carcinoma: pathogenesis, epidemiology, clinical features, diagnosis, histopathology, and management. Yale J Biol Med. 2015;88(2):167-79.

Namuduri RP, Lim TY, Yam PK, Gatsinga R, Lim-Tan SK, Chew SH, et al. Vulvar basal cell carcinoma: clinical features and treatment outcomes from a tertiary care centre. Singapore Med J. 2019;60(9):479-82. DOI: https://doi.org/10.11622/smedj.2019014

Rudd JC, Li C, Hajiannasab R, Khandalavala J, Sharma P. Diagnosing Basal Cell Carcinoma of the Vulva: A Case Report and Review of the Literature. Cureus. 2021;13(12):e20791. DOI: https://doi.org/10.7759/cureus.20791

de Hullu JA, van der Avoort IAM, Oonk MHM, van der Zee AGJ. Management of vulvar cancers. Eu J Surg Oncol. 2006;32(8):825-31. DOI: https://doi.org/10.1016/j.ejso.2006.03.035

Pleunis N, Schuurman MS, Van Rossum MM, Bulten J, Massuger LF, De Hullu JA, et al. Rare vulvar malignancies; incidence, treatment and survival in the Netherlands. Gynecol Oncol. 2016;142(3):440-5. DOI: https://doi.org/10.1016/j.ygyno.2016.04.021

Capria A, Tahir N, Fatehi M. Vulvar Cancer. In: StatPearls. Treasure Island (FL): StatPearls Publishing. 2025. Available at: https://www.ncbi. nlm.nih.gov/books/NBK567798/. Accessed on 28 September 2025.

Al-Sadek T, Yusuf N. Ultraviolet Radiation Biological and Medical Implications. Curr Issues Mol Biol. 2024;46(3):1924-42. DOI: https://doi.org/10.3390/cimb46030126

Tallon B. Basal cell carcinoma pathology. DermNet. 2016. Available at: https://dermnetnz.org/topics /basal-cell-carcinoma-pathology. Accessed on 28 September 2025.

Ozkanli S. Ber-EP4 staining patterns on basal cell carcinomas. North Clin Istanb. 2023;10(5):666-74. DOI: https://doi.org/10.14744/nci.2022.25675

Wirth P. SOX10. PathologyOutlines.com. 2024. Available at: https://www.pathologyoutlines.com/ topic/stainssox10.html. Accessed on 28 September 2025.

Chen-Yost HI, Antic T. Epithelial membrane antigen (EMA). PathologyOutlines.com. 2021. Available at: https://www.pathologyoutlines.com/topic/stainsema.html. Accessed on 28 September 2025.

Steurer S, Riemann C, Büscheck F, Luebke AM, Kluth M, Hube-Magg C, et al. p63 expression in human tumors and normal tissues: a tissue microarray study on 10,200 tumors. Biomark Res. 2021;9(1):7. DOI: https://doi.org/10.1186/s40364-021-00260-5

Sun X, Kaufman PD. Ki-67: more than a proliferation marker. Chromosoma. 2018;127(2):175-86. DOI: https://doi.org/10.1007/s00412-018-0659-8

Merlo S. Modern treatment of vulvar cancer. Radiol Oncol. 2020;54(4):371-6. DOI: https://doi.org/10.2478/raon-2020-0053

Celik H, Gurates B, Yavuz A, Dogan Z, Cobanoglu B, Saral Y. Vulvar basal cell carcinoma with clitoral involvement. Acta Derm Venereol. 2009;89(2):191-2. DOI: https://doi.org/10.2340/00015555-0566